All News

European Commission’s proposal to prevent national bans on environmental or health grounds is defeated

Gianotti, an Italian particle physicist instrumental in uncovering the Higgs Boson, will replace Rolf-Dieter Heuer, who led CERN through the launch of the Large Hadron Collider

Question mark hangs over whether the office of Chief Science Adviser is part of the European Commission’s future plans

Entrepreneur Hermann Hauser gives a positive account of the UK’s Fraunhofer-style innovation centres, but says further substantial investment is needed to exploit the country’s world-leading science base

Incremental innovation won’t do, experts say. At stake is leadership in life sciences, transportation, infrastructure and communications technologies

As a new European Commission sets to work, its energy-chief duo must make sure 2030 targets are met, bring down CO2 emissions and accelerate a single European energy market

Pressure builds on EU member states to agree a budget for 2015 that minimises hurt for researchers

In advance of a debate on GM crops in the European Parliament, a group of scientists tells governments to stop impeding trials

A low-cost text message programme to help young people improve their English language skills won the Science|Business inaugural Global Innovation Award earlier this month. Its founder, Elvis Austins, spells out how he got here and what comes next

Drive-AB has €9.4M to develop new business models to promote industry investment in antibiotics and prevent their inappropriate use

One-time head of IBM Europe and now an MEP, Hans-Olaf Henkel arrives in the EU capital to put his stamp on innovation policy and start a conversation on curtailing what he sees as Commission over-reach

The interdisciplinary vision of the future that inspired the formation of Aalto University has arrived. This has profound implications for undergraduate education, says the university’s President, Tuula Teeri. Students must be equipped to re-invent themselves, she tells Science|Business

InSphero’s breakthrough in generating 3D cell models of human organs at scale for use in toxicity screens attracted potential customers to invest in proving the technology. Now all the top ten pharma companies are users

Biologic drugs deliver health and wealth. But it is a long, fraught path from lab to bedside. Science|Business brought together research, business and policymakers to draft a risk-reduction plan for the new Parliament and Commission

Funding to be spent on clinical trials in Africa and assessing safety of experimental vaccine candidates. EMA to speed reviews.